From: 	Victoria Simms
To:	Publications
Date: 	07 September 2015 13:53
Subject: 	Fwd: Successful LID Submission
Attachments:	author's accepted manuscript.docx

Hello, 
here is the author's accepted copy for Research Online of a paper published in Lancet Infectious Diseases last month. I should have emailed you in June, sorry.

Best wishes,
Vicky Simms
 
>>> <luke.hunt@doctors.org.uk> 15/06/2015 17:38 >>>
Hi All,
I'm very happy to say that our paper has been accepted for publication by the Lancet ID. 
It's been a real collaborative effort and I want to thank you all for the hard work and dedication to this project. Personally it's also been a real learning curve so thank you for your support on this front. 
It's good to hear that others feel the work is of interest and am sure it will reflect well on the hard work of all staff who made Kerry Town a success.
I'll be in contact with the final paper following formatting etc.
Best wishes,
Luke

 
 
-------- Original Message --------

Subject:Submission to The Lancet Infectious Diseases
Date:2015-06-15 13:21
From:"Marco De Ambrogi" <m.deambrogi@elsevier.com>
To:luke.hunt@doctors.org.uk
 
Dear Luke, I am pleased to tell you that your submission, Clinical Presentation, Biochemical and Haematological Parameters and their Association with Outcome in Patients with Ebola Virus Disease: An observational Cohort Study., has been accepted for publication in The Lancet Infectious Diseases. Following publication, you will receive 100 free offprints. If you would like to order reprints, please contact the editorial office for a quote. Within the next weeks you will receive, electronically, a set of PDF page proofs of your article. Please note that because of our varied and international readership, The Lancet Infectious Diseases edits heavily to a strict house style. Thus, changes will inevitably be made to your manuscript at this time. There will also probably be a few final editorial queries at this stage. Please correct and return these pages by the deadline stated in the covering email. Because your paper is entered into our fast-track publication process this deadline will usually be between 24 and 48 hours. Please print out this email and complete the Transfer of Copyright Agreement below. Please retain a copy for your files and email a scanned copy to m.deambrogi@elsevier.com, alternatively you can fax a signed copy to: +44 (0)1865 853016. If you or any of your co-authors are employed directly by the World Health Organization, please contact us instead for a copy of the WHO/Elsevier non-exclusive licence agreement. Please contact me if you have any further queries regarding your manuscript. Yours Sincerely, Marco Marco De Ambrogi, PhD, Senior Editor TLID The Lancet Infectious Diseases Elsevier Lancet ID 125 London Wall London EC2Y 5AS UNITED KINGDOM Email: m.deambrogi@elsevier.com